Coleman Mark
SEC Form 4 insider trading activity
Coleman Mark has filed 7 SEC Form 4 filings (12 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Jun 11, 2026.
On the most recent filing, Coleman Mark is listed as Director at Axsome Therapeutics, Inc. Inside the rolling window, Coleman Mark reported no open-market purchases and 5 open-market sales totaling $8.2M in AXSM. The largest disclosed transaction in the window is a sale of 25,000 AXSM shares on Feb 26, 2026, worth $4.0M.
Companies traded
Other insiders at AXSM
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$8.2M
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Sep 8, 2025 | AXSM | Purchase | $62K |
| Sep 8, 2025 | AXSM | Purchase | $37K |
| Sep 8, 2025 | AXSM | Purchase | $102K |
Frequently asked questions
How many SEC Form 4 filings has Coleman Mark made?
Coleman Mark has filed 7 SEC Form 4 filings (12 transaction rows) across 1 company since 2025.
Which companies does Coleman Mark trade?
Coleman Mark has filed SEC Form 4 disclosures for 1 company, including AXSM.
When was Coleman Mark's most recent SEC Form 4 filing?
Coleman Mark's most recent SEC Form 4 filing on Tracefour is dated Jun 11, 2026.
What is Coleman Mark's total buy and sell value in the current window?
Inside the rolling retention window, Coleman Mark bought $0 and sold $8.2M based on SEC Form 4 filings.
What was Coleman Mark's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 25,000 AXSM shares on 2026-02-26, worth $4.0M, per SEC Form 4 filings.